Market Size of North America Stem Cell Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 9.50 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Stem Cell Market Analysis
The North American stem cell market is expected to witness a CAGR of 9.5% during the forecast period.
In the context of COVID-19, government organizations in various countries, research institutes, and many biotech and pharmaceutical firms were focusing on effective and rapid technologies for the fast diagnosis of COVID-19. According to a research article titled "Mesenchymal Stem Cell Therapy for COVID-19: Present or Future" published in April 2020, mesenchymal stem cells are a safe and effective approach to the treatment of COVID-19. Mesenchymal Stem Cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach and several clinical trials have begun. The positive results from such studies had led to the development of new therapies for COVID-19 and thus can propel the growth of the market. For instance, in May 2020, Lineage Cell Therapeutics received a grant of USD 5 million from the California Institute for Regenerative Medicine (CIRM) to support the use of vacuum filter-derived stromal cells, Lineage's allogeneic dendritic cell therapy, for the development of a potential vaccine against SARS-CoV-2, the virus that causes COVID-19. Thus, the COVID-19 had significant impact on market growth.
Factors such as increased awareness about umbilical stem cells and growing demand for regenerative treatment options, coupled with rising research and development initiatives to develop stem cell therapies and increasing approvals for clinical trials in stem cell research, are majorly driving the growth of the market. The area of stem cell-based therapies garners significant investments, and various clinical trials that require considerable support for expenditure are currently underway. Companies are fundraising to develop stem cell-based therapies to tackle many diseases. For instance, in January 2022, Cellino Biotech, a cell therapy manufacturing company, raised USD 80 million in Series A financing round. Cellino plans to expand access to stem cell-based therapies by building the first autonomous human cell foundry by 2025. As the applications of stem cell technologies in the treatment of diseases have ultimately increased, so has the overall adoption rate of these technologies across the region. This has led to increased investments by the market players for the development of novel therapies in this area.
Thus, owing to the abovementioned factors, the market is expected to project significant growth over the forecast period. However, expensive procedures and regulatory complications, may hinder the growth of the market.
North America Stem Cell Industry Segmentation
As per the scope of the report, stem cells are biological cells that can differentiate into other types of cells. Additionally, various types of stem cells are used for therapeutic purposes. With multiple applications at the clinical stage for various diseases, these are being explored extensively by a large number of biopharmaceutical companies in recent times. The North America Stem Cell Market is segmented by Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, and Other Product Types), Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, and Other Applications), Treatment Type (Allogeneic Stem Cell Therapy, Auto logic Stem Cell Therapy, and Syngeneic Stem Cell Therapy) and Geography. The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Adult Stem Cell | |
| Human Embryonic Cell | |
| Pluripotent Stem Cell | |
| Other Product Types |
| By Therapeutic Application | |
| Neurological Disorders | |
| Orthopedic Treatments | |
| Oncology Disorders | |
| Injuries and Wounds | |
| Cardiovascular Disorders | |
| Other Therapeutic Applications |
| By Treatment Type | |
| Allogeneic Stem Cell Therapy | |
| Auto logic Stem Cell Therapy | |
| Syngeneic Stem Cell Therapy |
| Geography | |
| United States | |
| Canada | |
| Mexico |
North America Stem Cell Market Size Summary
The North American stem cell market is poised for significant growth, driven by increased awareness and demand for regenerative treatments, alongside rising research and development initiatives. The market's expansion is further bolstered by the growing number of clinical trials and approvals in stem cell research. The COVID-19 pandemic has also played a pivotal role in accelerating market growth, as mesenchymal stem cells were explored as a therapeutic approach, leading to the development of new therapies. This surge in interest and investment in stem cell-based therapies is expected to continue, despite challenges such as high costs and regulatory complexities. The market's growth is also supported by the increasing burden of cancer, necessitating advancements in cancer therapies, including stem cell transplants.
The United States is anticipated to maintain a dominant position in the North American stem cell market, attributed to its robust regulatory framework, presence of key industry players, and leading research institutions. The market's growth is fueled by the rising prevalence of chronic conditions, the adoption of regenerative medicine, and the proliferation of clinical studies on cellular therapies. Significant investments from market players, such as Cellino Biotech's fundraising efforts, are driving the development and expansion of cell-based therapies. The market is characterized by intense competition, with major players like Becton, Dickinson and Company, and Thermo Fisher Scientific focusing on R&D and strategic partnerships to enhance their market presence. Positive outcomes from stem cell therapy products are expected to further propel market growth, with ongoing developments in therapeutic applications across various medical conditions.
North America Stem Cell Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Introduction to Market Drivers and Restraints
-
1.3 Market Drivers
-
1.3.1 Increase in the Approval for Clinical Trials in Stem Cell Research
-
1.3.2 Growing Demand for Regenerative Treatment Option
-
1.3.3 Rising R&D Initiatives to Develop Therapeutic Options for Chronic Diseases
-
-
1.4 Market Restraints
-
1.4.1 Expensive Procedures
-
1.4.2 Regulatory Complications
-
-
1.5 Porter's Five Forces Analysis
-
1.5.1 Threat of New Entrants
-
1.5.2 Bargaining Power of Buyers/Consumers
-
1.5.3 Bargaining Power of Suppliers
-
1.5.4 Threat of Substitute Products
-
1.5.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Adult Stem Cell
-
2.1.2 Human Embryonic Cell
-
2.1.3 Pluripotent Stem Cell
-
2.1.4 Other Product Types
-
-
2.2 By Therapeutic Application
-
2.2.1 Neurological Disorders
-
2.2.2 Orthopedic Treatments
-
2.2.3 Oncology Disorders
-
2.2.4 Injuries and Wounds
-
2.2.5 Cardiovascular Disorders
-
2.2.6 Other Therapeutic Applications
-
-
2.3 By Treatment Type
-
2.3.1 Allogeneic Stem Cell Therapy
-
2.3.2 Auto logic Stem Cell Therapy
-
2.3.3 Syngeneic Stem Cell Therapy
-
-
2.4 Geography
-
2.4.1 United States
-
2.4.2 Canada
-
2.4.3 Mexico
-
-
North America Stem Cell Market Size FAQs
What is the current North America Stem Cell Market size?
The North America Stem Cell Market is projected to register a CAGR of 9.5% during the forecast period (2024-2029)
Who are the key players in North America Stem Cell Market?
Becton, Dickinson and Company, Thermo Fisher Scientific, Lineage Cell Therapeutics, Inc.,, Merck KGaA (Sigma Aldrich) and Bristol-Myers Squibb Company are the major companies operating in the North America Stem Cell Market.
